Karaman-Kutluay, Y. Et Al. 2019. Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice. European-Respiratory-Society (ERS) International Congress , (Madrid, Spain).

Karaman-Kutluay, Y., KAYA YAŞAR, Y., BOZKURT, T. E., ÖNDER, S. Ç., & Sahin-Erdemli, I., (2019). Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice . European-Respiratory-Society (ERS) International Congress, Madrid, Spain

Karaman-Kutluay, Yasemin Et Al. "Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice," European-Respiratory-Society (ERS) International Congress, Madrid, Spain, 2019

Karaman-Kutluay, Yasemin Et Al. "Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice." European-Respiratory-Society (ERS) International Congress , Madrid, Spain, 2019

Karaman-Kutluay, Y. Et Al. (2019) . "Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice." European-Respiratory-Society (ERS) International Congress , Madrid, Spain.

@conferencepaper{conferencepaper, author={Yasemin Karaman-Kutluay Et Al. }, title={Intranasal treatment with the mitochondria-targeted slow hydrogen sulfide releasing donor AP39 prevents inflammation-induced airway hyperreactivity in mice}, congress name={European-Respiratory-Society (ERS) International Congress}, city={Madrid}, country={Spain}, year={2019}}